Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.
Clinical trial NCT05615142 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05615142
- Sponsor
- Sichuan University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-15
- Primary completion
- 2024-04-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.